|
Targeting SS18-SSX biology in synovial sarcomagenesis
|
1U54CA231652-01
|
$11,520,799
|
JONES, KEVIN
|
UNIVERSITY OF UTAH
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
2P01CA013106-46A1
|
$4,537,433
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
SPORE in Prostate Cancer
|
5P50CA092629-18
|
$2,436,043
|
SCHER, HOWARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,313,288
|
Edelman, Daniel
|
CCR (NCI)
|
|
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
|
5P50CA174521-04
|
$2,300,000
|
O'DORISIO, M SUE
|
UNIVERSITY OF IOWA
|
|
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
|
5P50CA070907-20
|
$2,299,999
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-14
|
$1,999,508
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
|
5P01CA117969-13
|
$1,980,694
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Clinical and Genetic Studies of Li Fraumeni Syndrome
|
ZIA CP010144 10503
|
$1,976,426
|
Savage, Sharon
|
DCEG (NCI)
|
|
Roles and Regulation of wild-type and mutant forms of p53
|
5P01CA087497-17
|
$1,885,586
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Mechanisms of Breast Development and Carcinogenesis
|
5P01CA080111-20
|
$1,871,103
|
WEINBERG, ROBERT
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-08
|
$1,870,359
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
|
5P01CA154303-07
|
$1,846,173
|
MEYERSON, MATTHEW
|
DANA-FARBER CANCER INST
|
|
Integrated EGFR function in cytokine-driven inflammation and cancer
|
5P01CA062220-23
|
$1,805,475
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Targets for Therapy for Carcinomas of the Lung
|
2P01CA129243-11
|
$1,725,669
|
KRIS, MARK
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-08
|
$1,691,502
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
p53, Aging, and Cancer
|
ZIA BC 011496
|
$1,619,072
|
Harris, Curtis
|
CCR (NCI)
|
|
Human Cancer Suppressor Functions of Protein Phosphatase 2A
|
5P01CA203655-02
|
$1,613,905
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Defining RAS isoform- and mutation-specific roles in oncogenesis
|
5P01CA203657-03
|
$1,539,964
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
CCR Collaborative Bioinformatics Resource
|
ZIC BC 011532
|
$1,438,274
|
Goldstein, David
|
CCR (NCI)
|
|
Characterization of the Osteosarcoma Genome
|
ZIA BC 011328
|
$1,391,089
|
Meltzer, Paul
|
CCR (NCI)
|
|
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
|
5U01CA217858-02
|
$1,314,469
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Relationship between DNA damage detection and signaling
|
ZIA BC 010959
|
$1,309,141
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-15
|
$1,298,387
|
HANNUN, YUSUF
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Protein Structure
|
ZIA BC 010348
|
$1,173,857
|
Wlodawer, Alexander
|
CCR (NCI)
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-13
|
$1,170,535
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer genes: translating basics to applications
|
5R35CA197582-03
|
$1,154,070
|
VOGT, PETER
|
SCRIPPS RESEARCH INSTITUTE
|
|
Identification of Nucleic Acid Binding Small Molecules
|
ZIA BC 011585
|
$1,144,983
|
Schneekloth, John
|
CCR (NCI)
|
|
T cell Development and Regeneration
|
ZIA BC 011633
|
$1,139,421
|
Bhandoola, Avinash
|
CCR (NCI)
|
|
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity
|
5R35CA197687-04
|
$1,129,825
|
WAHL, GEOFFREY
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$1,100,630
|
Westlake, Christopher
|
CCR (NCI)
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$1,096,129
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership
|
5U54CA118638-13
|
$1,090,193
|
LILLARD, JAMES
|
MOREHOUSE SCHOOL OF MEDICINE
|
|
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
|
5R35CA210064-03
|
$1,046,441
|
LOOK, A
|
DANA-FARBER CANCER INST
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$1,046,209
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
|
ZIA BC 011208
|
$1,044,840
|
Grewal, Shiv
|
CCR (NCI)
|
|
Targeting Tumor Suppressive Pathways for Cancer Therapy
|
5R35CA197529-04
|
$1,044,000
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
|
5R35CA220500-02
|
$1,032,000
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Role of C/EBP transcription factors in cell growth and tumorigenesis
|
ZIA BC 010328
|
$986,297
|
Johnson, Peter
|
CCR (NCI)
|
|
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
|
5R35CA197591-04
|
$977,640
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-03
|
$968,501
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The Role of Wnt Genes in Vertebrate Development and Cancer
|
ZIA BC 010345
|
$967,351
|
Yamaguchi, Terry
|
CCR (NCI)
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$964,491
|
Larson, Daniel
|
CCR (NCI)
|
|
Molecular diagnosis and outcome prediction in lymphoma
|
ZIA BC 011006
|
$955,342
|
Staudt, Louis
|
CCR (NCI)
|
|
RNA interference-based screens for molecular targets in cancer
|
ZIA BC 011007
|
$955,342
|
Staudt, Louis
|
CCR (NCI)
|
|
Oncogenic mechanisms and molecular targets in lymphoma
|
ZIA BC 011008
|
$955,342
|
Staudt, Louis
|
CCR (NCI)
|
|
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
|
5U01CA217851-02
|
$946,251
|
KUO, CALVIN
|
STANFORD UNIVERSITY
|
|
New Ways of Targeting K-Ras
|
5R35CA197709-03
|
$944,270
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|